Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kaiser

Showing results (351-360 of 554) with videos related to

Pageof 56
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina|October 14, 2022
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b StudyDavid S Boyer, Peter K Kaiser, George N Magrath, et al.
The British Journal of Ophthalmology|October 25, 2012
Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomographyDilsher S Dhoot, Siya Huo, Alex Yuan, et al.
Ophthalmology. Retina|May 8, 2024
Imaging Characteristics and Clinical Utility of Half-Dose versus Full-Dose Ultrawidefield Fundus Fluorescein AngiographyAndrei Szigiato, Sumit Sharma, Sandeep Singh, et al.
ACS Nano|June 5, 2024
Deconvoluting the Individual Effects of Nanoparticle Proximity and Size in ThermocatalysisKang Rui Garrick Lim, Selina K Kaiser, Haichao Wu, et al.
Biochimica Et Biophysica Acta|August 21, 1996
The effects of post-translational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopesL Otvos, B Cappelletto, I Varga, et al.
Genomics|December 1, 1994
Enhanced access to rare brain cDNAs by prescreening libraries: 207 new mouse brain ESTsR W Davies, A B Roberts, A J Morris, et al.
Diabetes, Obesity & Metabolism|September 20, 2012
Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitusL Nosek, J-M Cardot, D R Owens, et al.
Retina (Philadelphia, Pa.)|September 17, 2024
EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results From the Phase 3 Mylight StudyArnaldo F Bordon, Peter K Kaiser, Armin Wolf, et al.
Developments in Ophthalmology|October 27, 2015
Future Perspectives: Agents on the HorizonJose R Maya, Mohammad Ali Sadiq, Aniruddha Agarwal, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 8, 2015
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysisRishi P Singh, Sunil K Srivastava, Justis P Ehlers, et al.
Pageof 56

Showing results (351-360 of 554) with videos related to

Sort By:
Pageof 56
Ophthalmic Surgery, Lasers & Imaging Retina|October 14, 2022
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b StudyDavid S Boyer, Peter K Kaiser, George N Magrath, et al.
The British Journal of Ophthalmology|October 25, 2012
Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomographyDilsher S Dhoot, Siya Huo, Alex Yuan, et al.
Ophthalmology. Retina|May 8, 2024
Imaging Characteristics and Clinical Utility of Half-Dose versus Full-Dose Ultrawidefield Fundus Fluorescein AngiographyAndrei Szigiato, Sumit Sharma, Sandeep Singh, et al.
ACS Nano|June 5, 2024
Deconvoluting the Individual Effects of Nanoparticle Proximity and Size in ThermocatalysisKang Rui Garrick Lim, Selina K Kaiser, Haichao Wu, et al.
Biochimica Et Biophysica Acta|August 21, 1996
The effects of post-translational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopesL Otvos, B Cappelletto, I Varga, et al.
Genomics|December 1, 1994
Enhanced access to rare brain cDNAs by prescreening libraries: 207 new mouse brain ESTsR W Davies, A B Roberts, A J Morris, et al.
Diabetes, Obesity & Metabolism|September 20, 2012
Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitusL Nosek, J-M Cardot, D R Owens, et al.
Retina (Philadelphia, Pa.)|September 17, 2024
EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results From the Phase 3 Mylight StudyArnaldo F Bordon, Peter K Kaiser, Armin Wolf, et al.
Developments in Ophthalmology|October 27, 2015
Future Perspectives: Agents on the HorizonJose R Maya, Mohammad Ali Sadiq, Aniruddha Agarwal, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 8, 2015
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysisRishi P Singh, Sunil K Srivastava, Justis P Ehlers, et al.
Pageof 56